Home Healthcare Biotechnology Neoantigen Cancer Vaccine Market

Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalised Neoantigen Vaccine, Off-the-Shelf Neoantigen Vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic Acid, Dendritic Cell, Tumour Cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Gene Gun, Electroporation, Others), By Application (Lung, Melanoma, Gastrointestinal, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
  7. North America Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  8. Europe Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    16. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    17. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  9. APAC Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  10. Middle East and Africa Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  11. LATAM Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  12. Competitive Landscape
    1. Neoantigen Cancer Vaccine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. OSE Immunotherapeutics SA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gritstone bio Inc.
    3. BioNTech SE
    4. Hoffmann-La Roche Ltd.
    5. Pfizer Inc.
    6. Merck & Co. Inc.
    7. Moderna Inc.
    8. Avidea Technologies Inc.
    9. Eli Lilly and Company
    10. Vaccibody AS
    11. Agenus Inc.
    12. Novogene Co. Ltd.
    13. ZIOPHARM Oncology Inc.
    14. ISA Pharmaceuticals B.V.
    15. BrightPath Biotherapeutics Co. Ltd.
    16. Vaximm AG
    17. Medigene AG
    18. Genocea Biosciences Inc.
    19. Advaxis Inc.
    20. Nouscom AG
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Neoantigen Cancer Vaccine Market Size and Forecast By Regions - 2022-2034 (USD Million)

Table 2: Global Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 3: Global Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 4: Global Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 5: Global Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 6: Global Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 7: Global Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 8: Global Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 9: North America Neoantigen Cancer Vaccine Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 10: North America Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 11: North America Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 12: North America Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 13: North America Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 14: North America Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 15: North America Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 16: North America Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 17: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 18: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 19: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 20: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 21: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 22: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 23: U.S. Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 24: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 25: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 26: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 27: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 28: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 29: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 30: Canada Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 31: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 32: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 33: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 34: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 35: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 36: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 37: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 38: Europe Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 39: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 40: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 41: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 42: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 43: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 44: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 45: U.K. Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 46: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 47: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 48: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 49: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 50: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 51: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 52: Germany Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 53: France Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 54: France Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 55: France Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 56: France Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 57: France Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 58: France Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 59: France Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 60: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 61: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 62: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 63: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 64: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 65: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 66: Spain Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 67: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 68: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 69: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 70: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 71: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 72: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 73: Italy Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 74: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 75: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 76: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 77: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 78: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 79: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 80: Russia Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 81: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 82: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 83: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 84: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 85: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 86: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 87: Nordic Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 88: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 89: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 90: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 91: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 92: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 93: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 94: Benelux Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 95: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 96: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 97: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 98: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 99: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 100: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 101: Rest of Europe Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 102: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 103: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 104: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 105: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 106: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 107: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 108: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 109: APAC Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 110: China Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 111: China Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 112: China Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 113: China Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 114: China Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 115: China Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 116: China Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 117: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 118: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 119: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 120: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 121: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 122: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 123: Korea Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 124: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 125: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 126: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 127: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 128: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 129: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 130: Japan Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 131: India Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 132: India Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 133: India Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 134: India Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 135: India Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 136: India Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 137: India Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 138: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 139: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 140: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 141: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 142: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 143: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 144: Australia Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 145: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 146: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 147: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 148: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 149: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 150: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 151: Taiwan Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 152: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 153: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 154: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 155: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 156: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 157: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 158: South East Asia Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 159: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 160: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 161: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 162: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 163: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 164: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 165: Rest of Asia-Pacific Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 166: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 167: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 168: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 169: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 170: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 171: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 172: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 173: Middle East and Africa Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 174: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 175: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 176: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 177: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 178: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 179: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 180: UAE Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 181: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 182: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 183: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 184: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 185: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 186: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 187: Turkey Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 188: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 189: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 190: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 191: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 192: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 193: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 194: Saudi Arabia Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 195: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 196: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 197: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 198: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 199: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 200: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 201: South Africa Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 202: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 203: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 204: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 205: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 206: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 207: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 208: Egypt Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 209: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 210: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 211: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 212: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 213: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 214: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 215: Nigeria Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 216: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 217: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 218: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 219: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 220: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 221: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 222: Rest of MEA Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 223: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 224: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 225: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 226: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 227: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 228: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 229: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 230: LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 231: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 232: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 233: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 234: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 235: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 236: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 237: Brazil Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 238: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 239: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 240: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 241: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 242: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 243: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 244: Mexico Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 245: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 246: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 247: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 248: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 249: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 250: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 251: Argentina Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 252: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 253: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 254: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 255: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 256: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 257: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 258: Chile Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 259: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 260: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 261: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 262: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 263: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 264: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 265: Colombia Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 266: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 267: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Neoantigen Type - 2022-2034 (USD Million)

Table 268: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Route of Administration - 2022-2034 (USD Million)

Table 269: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Cell - 2022-2034 (USD Million)

Table 270: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Technology - 2022-2034 (USD Million)

Table 271: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Delivery Mechanism - 2022-2034 (USD Million)

Table 272: Rest of LATAM Neoantigen Cancer Vaccine Market Size and Forecast By Application - 2022-2034 (USD Million)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.